Synthesis and Characterization of Rhenium(V) Complexes Having 3-(4-m-Chlorophenylpiperazin-1-yl)butane-1-thiol as Coligand toward 5HT2A Specific Radiopharmaceuticals

Byung Chul Choi; Hee Kwon Chae; Hyun-Joon Ha; Jung Young Kim; Seung Jun Oh

首页> 外文期刊>Bulletin of the Korean Chemical Society >Synthesis and Characterization of Rhenium(V) Complexes Having 3-(4-m-Chlorophenylpiperazin-1-yl)butane-1-thiol as Coligand toward 5HT2A Specific Radiopharmaceuticals

【24h】

Synthesis and Characterization of Rhenium(V) Complexes Having 3-(4-m-Chlorophenylpiperazin-1-yl)butane-1-thiol as Coligand toward 5HT2A Specific Radiopharmaceuticals

机译：以3-（4-间-氯苯基哌嗪-1-基）丁烷-1-硫醇为配体的toward（V）配合物的合成及表征，针对5HT2A特定放射性药物

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Bulletin of the Korean Chemical Society》 |2003年第10期|共页
作者
Byung Chul Choi; Hee Kwon Chae; Hyun-Joon Ha; Jung Young Kim; Seung Jun Oh;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类化学;
关键词

相似文献

外文文献
中文文献
专利

1. Functionalized rhenium(V) organoimido complexes as potential radiopharmaceuticals. 2. Synthesis, structural characterization, and reactivity of N-succinimidyl ester derivatives with amines [J] . Arterburn JB., Goreham DM., Valenzuela MV., Organometallics . 2000,第9期

机译：功能化rh（V）有机亚胺基配合物作为潜在的放射性药物。 2. N-琥珀酰亚胺酯衍生物与胺的合成，结构表征和反应性
2. Synthesis,Characterization and Bioactivity of Cobalt(II)Complexes with Benzoylidenepyridine-2-,3- and 4-hydroxyaniline and Nitrate or Perchlorate as Coligands [J] . JEYA RAJENDRAN, C.JOTHILAKSHMI, P.AGASTIAN Asian Journal of Chemistry: An International Quarterly Research Journal of Chemistry . 2006,第2期

机译：以苯并亚苄基吡啶-2-，3-和4-羟基苯胺和硝酸盐或高氯酸盐为配体的钴（II）配合物的合成，表征和生物活性
3. Synthesis, characterization and biological evaluation of (188Re(N)(cys approximately )(PNP))+/0 mixed-ligand complexes as prototypes for the development of 188Re(N)-based target-specific radiopharmaceuticals. [J] . Thieme S, Agostini S, Bergmann R, Nuclear Medicine and Biology . 2011,第3期

机译：（188Re（N）（cys近似）（PNP））+ / 0混合配体复合物的合成，表征和生物学评估，作为开发基于188Re（N）的靶标特异性放射性药物的原型。
4. Complexes of 2-(4-aminophenyl)benzothiazole derivatives withtechnetium and rhenium and assessment of their properties asdiagnostic and/or therapeutic radiopharmaceuticals [C] . S.Tzanopoulou, G.Patsis, M.Sagnou, Trends in Radiopharmaceuticals(ISTR-2005) . 2007

机译：2-（4-氨基苯基）苯并噻唑衍生物与tech和的配合物及其对诊断和/或治疗性放射性药物的性能评估
5. STUDIES OF TECHNETIUM AND RHENIUM DIPHOSPHINE COMPLEXES, AND SOME CATIONIC TECHNETIUM COMPLEXES OF SCHIFF BASE LIGANDS, AS MYOCARDIAL IMAGING AGENTS (RADIOPHARMACEUTICALS). [D] . VANDERHEYDEN, JEAN-LUC E. 1985

机译：作为心肌成像剂（放射性药物）的S夫碱配体的OF和AND二膦配合物以及某些阳离子配合物的研究。
6. Syntheses and structural characterization of rhenium-bis-hydrazinopyrimidine core complexes with thiolate and Schiff base coligands [O] . Frank J. Femia, Xiaoyuan Chen, Kevin P. Maresca, -1

机译：-双肼基嘧啶核心配合物与硫醇盐和席夫碱大肠菌素的合成及结构表征
7. Design, synthesis and characterization of novel rhenium(V) and technetium(V) complexes as potential radiopharmaceuticals [O] . Hlabela Patrick Simon 2001

机译：设计，合成和表征新型potential（V）和complex（V）配合物作为潜在的放射性药物

Synthesis and Characterization of Rhenium(V) Complexes Having 3-(4-m-Chlorophenylpiperazin-1-yl)butane-1-thiol as Coligand toward 5HT2A Specific Radiopharmaceuticals

著录项

引文网络

相似文献

相关主题

期刊订阅